6 completed. 6 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Completed 6 |
Follow Hypothalamic Neoplasms: new trials by email Literature Review of Hypothalamic Neoplasms trials Research Report on Hypothalamic Neoplasms
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Nivolumab and Ipilimumab in People With Aggressive Pituitary Tumors Ipilimumab, Nivolumab - Pituitary, Pituitary Tumor | Phase 2 | Completed | Memorial Sloan Kettering Cancer Center | 10 | 2019-07-31 | 2026-06-02 |
| Efficacy and Safety of Pasireotide LAR (Long-acting Release) in Japanese Patients With Acromegaly or Pituitary Gigantism Pasireotide LAR - Acromegaly, Pituitary Gigantism | Phase 2 | Completed | Novartis Pharmaceuticals | 33 | 2012-10-16 | 2019-09-16 |
| Targeted Therapy With Lapatinib in Patients With Recurrent Pituitary Tumors Resistant to Standard Therapy Lapatinib - Pituitary Adenomas, Prolactinomas | Phase 2 | Completed | Cedars-Sinai Medical Center | 9 | 2009-07-01 | 2020-01-22 |
| Study of Thyrotropin-Releasing Hormone in Normal Volunteers and in Patients With Thyroid or Pituitary Abnormalities TRH (Thyrotropin Releasing Hormone) - Healthy, Pituitary Disease | Phase 2 | Completed | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 96 | 2003-02-07 | 2018-08-08 |
| Safety and Efficacy of FolateScan (Technetium Tc 99m EC20) in Subjects With Pituitary Tumors Technetium Tc 99m EC20 - Pituitary Tumors | Phase 2 | Completed | Endocyte | 40 | 2002-09-01 | 2023-06-22 |
| Sandostatin LAR Depot vs. Surgery for Treating Acromegaly Sandostatin LAR Depot versus transsphenoidal surgery - Acromegaly, Pituitary Neoplasm | Phase 2 | Completed | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 5 | 1999-08-01 | 2008-03-04 |
Pituitary Neoplasms (6) · Acromegaly (2) · Pituitary Diseases (2) · Gigantism (1) · Growth Disorders (1) · Hypothyroidism (1) · Prolactinoma (1) · Thyroid Diseases (1)
Brain Diseases (6) · Brain Neoplasms (6) · Central Nervous System Diseases (6) · Central Nervous System Neoplasms (6) · Endocrine Gland Neoplasms (6) · Endocrine System Diseases (6) · Hypothalamic Diseases (6) · Neoplasms (6) · Neoplasms by Site (6) · Nervous System Diseases (6) · Nervous System Neoplasms (6) · Supratentorial Neoplasms (6) · Pituitary Diseases (4) · Bone Diseases (2)
Ipilimumab (1) · Lapatinib (1) · Nivolumab (1) · Thyrotropin-Releasing Hormone (1) · pasireotide (1)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (2) · Cedars-Sinai Medical Center (1) · Endocyte (1) · Memorial Sloan Kettering Cancer Center (1) · Novartis Pharmaceuticals (1)
United States (5) · Japan (1)
Andrew Lin, MD (1) · Joanna Klubo-Gwiezdzinska, M.D. (1) · Nelson Oyesiku, MD (1) · Odelia Cooper, MD (1)